|
University
of
Medicine
and Dentistry of
New Jersey:
·
Endocarditis
·
Fenfluramine-Phentermine valvular disease
·
PPH: Pulmonary hypertension
FDA Announces Withdrawal of Fenfluramine and Dexfenfluramine
FDA Homepage
·
FDA Fen-Phen information page, including updates as well as the "U.S.
Department of Health and Human Services Interim Recommendations Issued
for Patients Exposed to Fenfluramine and Dexfenfluramine."
·
"Dear Health Care Professional" letters by pharmaceutical companies.
Referenced drugs include Ionamin, Phen/Fen, Pondimin, and Pondimin and
Redux.
·
FDA Analysis of Cardiac Valvular Dysfunction with Use of Appetite
Suppressants
·
FDA Medwatch
Ed Friedlander, M.D., - Welcome to Ed's Pathology Notes, placed here
originally for the convenience of medical students at my school. You
need to check the accuracy of any information, from any source, against
other credible sources. I cannot diagnose or treat over the web, I
cannot comment on the health care you have already received, and these
notes cannot substitute for your own doctor's care. I am good at helping
people find resources and answers. If you need me, send me an e-mail at
erf@uhs.edu Your confidentiality is completely respected.
Do I have a
Fen Phen case?
|
 |
